EmpNia
EmpNia is a medical technology company that develops and sells the FDA-cleared eMotus system, a disposable wearable fiber optic sensor and tracking software for respiratory motion management during radiation therapy and diagnostic imaging, serving radiation oncology departments and cancer treatment centers in the United States.
- Company typePrivate
- Founded2020
- HeadquartersEden Prairie, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What EmpNia does
EmpNia Inc. is a Delaware-incorporated medical technology company headquartered in Eden Prairie, Minnesota, founded in March 2020 by Manojeet Bhattacharya, PhD, formerly a Key Expert in the Molecular Imaging division of Siemens Healthineers. The company develops and markets the EmpNia eMotus system, an FDA 510(k)-cleared Class II wearable fiber optic sensing solution for respiratory motion management during radiation therapy and diagnostic imaging procedures. The eMotus system consists of a disposable fiber optic sensor (approximately the width of a human hair, attached to the patient's chest via clear tape) paired with tracking software that visualizes breathing pace, frequency, and amplitude and communicates a Gate signal to external imaging and radiation therapy systems for beam-gating and organ position verification.
EmpNia firmographics
Firmographics- Name
- EmpNia
- Legal name
- EmpNia Inc.
- Website
- https://empnia.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EmpNia is a medical technology company that develops and sells the FDA-cleared eMotus system, a disposable wearable fiber optic sensor and tracking software for respiratory motion management during radiation therapy and diagnostic imaging, serving radiation oncology departments and cancer treatment centers in the United States.
- Ownership category
- akta.pro rank
Where EmpNia is headquartered
LocationHeadquarters
- HQ city
- Eden Prairie
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
EmpNia business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- eMotus Disposable Sensors: Disposable fiber optic sensors sold to healthcare providers for single-patient use during radiation therapy procedures. The first introduction of a disposable device for motion management in this category.
- eMotus Software/Platform: Software licensing or subscription model for the tracking software that accompanies the fiber optic sensor hardware, enabling waveform visualization and gate signal communication.
- Capital Equipment Avoidance Model: Revenue generated by eliminating the need for healthcare providers to purchase bulky capital equipment, making the solution cost-effective with no upfront capital purchase required.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
EmpNia product offering
Product offeringCore offering
EmpNia develops and sells the eMotus™ System, an FDA-cleared wearable fiber optic sensor paired with proprietary tracking software that measures patient respiratory motion in real time. The disposable sensor attaches to the patient's chest and feeds motion data into software that displays breathing waveform visualizations and emits a Gate signal to synchronize radiation beam activation with the patient's breathing cycle. The system is sold to hospitals, radiation oncology departments, and cancer treatment centers to enable precision image-guided radiation therapy and improve diagnostic imaging quality.
Product overview
EmpNia offers a single unified product: the EmpNia eMotus™ System, which consists of a wearable fiber optic sensor and tracking software. The wearable sensor is a disposable device that attaches to the patient's chest to measure and record respiratory waveforms, while the software translates this motion data into visual indicators (green bars and waveform charts) that clinicians use to synchronize radiation beam delivery with patient breathing cycles.
Differentiator
Problem solved
Functional benefit
Brands
- eMotus: FDA-cleared wearable fiber optic sensing solution for respiratory motion management in image-guided radiation therapy
Products and services
- EmpNia eMotus™ System FDA-cleared (510(k)) Class II medical device combining a disposable wearable fiber optic sensor (approximately the width of a human hair, attached to the patient's chest via clear tape) with proprietary tracking software. The sensor measures respiratory motion in real time and the software displays breathing waveform visualizations and Gate signals to synchronize radiation beam activation with the patient's breathing cycle. Designed for radiation oncology departments, hospitals, and cancer treatment centers performing external beam radiation therapy, CT diagnostic imaging, and respiratory-synchronized image acquisition.
Companies that use EmpNia
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
EmpNia technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
EmpNia partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Multiple Large OEMs (Diagnostic Imaging and Radiation Therapy)coreStrategic partnerships with large OEMs in the diagnostic imaging and radiation therapy industry for system integration and distribution of the eMotus technology. These partnerships are key to achieving universal compatibility across imaging and therapy systems.
Scale indicators4 records
Recent moves8 records
Expansion highlights6 records
EmpNia competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights6 records
Customer concentration
EmpNia social profiles
Digital presenceEmpNia compliance and trust
Trust signalCompliance1 record
EmpNia financial estimates
Financial estimateRevenue estimate
Valuation estimate
EmpNia leadership team
Management profileNumber of profiles
Profiles7 records
EmpNia funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EmpNia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EmpNia
What does EmpNia do?
EmpNia develops and sells the eMotus™ System, an FDA-cleared wearable fiber optic sensor paired with proprietary tracking software that measures patient respiratory motion in real time. The disposable sensor attaches to the patient's chest and feeds motion data into software that displays breathing waveform visualizations and emits a Gate signal to synchronize radiation beam activation with the patient's breathing cycle. The system is sold to hospitals, radiation oncology departments, and cancer treatment centers to enable precision image-guided radiation therapy and improve diagnostic imaging quality.
Is EmpNia a public or private company?
EmpNia is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was EmpNia founded?
EmpNia was founded in 2020. It employs 11 to 50 people.
Where is EmpNia based?
EmpNia is headquartered in Eden Prairie, United States, in the North America region.
How does EmpNia make money?
Three revenue lines are on record. eMotus Disposable Sensors are the primary driver. The others are eMotus Software/Platform and capital Equipment Avoidance Model.
Does EmpNia have an API?
No public API is recorded for EmpNia.